TimesSquare Capital Management LLC lessened its holdings in shares of Maximus, Inc. (NYSE:MMS) by 6.7% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 675,700 shares of the health services provider’s stock after selling 48,600 shares during the quarter. TimesSquare Capital Management LLC owned about 1.04% of Maximus worth $42,319,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also modified their holdings of MMS. Teacher Retirement System of Texas raised its holdings in Maximus by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 5,174 shares of the health services provider’s stock valued at $324,000 after acquiring an additional 14 shares in the last quarter. Alps Advisors Inc. raised its holdings in Maximus by 0.3% in the second quarter. Alps Advisors Inc. now owns 7,807 shares of the health services provider’s stock valued at $489,000 after acquiring an additional 20 shares in the last quarter. World Asset Management Inc raised its holdings in Maximus by 0.8% in the first quarter. World Asset Management Inc now owns 3,976 shares of the health services provider’s stock valued at $247,000 after acquiring an additional 30 shares in the last quarter. Neuburgh Advisers LLC raised its holdings in Maximus by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock valued at $105,000 after acquiring an additional 32 shares in the last quarter. Finally, Northwestern Mutual Investment Management Company LLC raised its holdings in Maximus by 0.3% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 11,206 shares of the health services provider’s stock valued at $620,000 after acquiring an additional 36 shares in the last quarter. 97.22% of the stock is currently owned by institutional investors and hedge funds.
Maximus, Inc. (NYSE MMS) opened at 60.62 on Friday. The firm has a 50-day moving average of $60.39 and a 200 day moving average of $61.35. The stock has a market capitalization of $3.93 billion, a price-to-earnings ratio of 19.43 and a beta of 1.37. Maximus, Inc. has a 52 week low of $43.69 and a 52 week high of $64.97.
Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.03. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The company had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. During the same period in the prior year, the company posted $0.79 EPS. Maximus’s quarterly revenue was down 2.7% on a year-over-year basis. On average, analysts anticipate that Maximus, Inc. will post $3.13 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th were given a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date of this dividend was Friday, August 11th. Maximus’s payout ratio is 5.73%.
MMS has been the topic of several analyst reports. Robert W. Baird initiated coverage on shares of Maximus in a report on Sunday, September 3rd. They issued a “neutral” rating on the stock. Canaccord Genuity cut shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price on the stock. in a report on Tuesday, July 4th. ValuEngine cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Tuesday, May 16th. KeyCorp reaffirmed a “sector weight” rating on shares of Maximus in a report on Thursday, May 25th. Finally, BidaskClub cut shares of Maximus from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 6th. One research analyst has rated the stock with a sell rating and nine have issued a hold rating to the stock. The company currently has an average rating of “Hold” and an average price target of $62.43.
In other Maximus news, CEO Richard A. Montoni sold 29,203 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $60.38, for a total value of $1,763,277.14. Following the transaction, the chief executive officer now directly owns 549,215 shares of the company’s stock, valued at approximately $33,161,601.70. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, General Counsel David Francis sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $58.89, for a total value of $117,780.00. Following the completion of the transaction, the general counsel now directly owns 13,716 shares in the company, valued at $807,735.24. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 108,403 shares of company stock worth $6,586,731. 3.10% of the stock is currently owned by corporate insiders.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.